Short-Term Treatment Outcomes of Brolucizumab in Patients with Neovascular Age-Related Macular Degeneration: A Multicentre Indian Real-World Evidence Study.

Chakraborty, Debdulal; Thakkar, Milan; Venkatesh, Ramesh; Roy, Sangeeta; Bhavsar, Maulik; Karcher, Helene

Chakraborty, Debdulal; Thakkar, Milan; Venkatesh, Ramesh; Roy, Sangeeta; Bhavsar, Maulik; Karcher, Helene.

Afiliação

Chakraborty D; Disha Eye Hospital, Kolkata, West Bengal, India.
Thakkar M; Dr. Milan's Retina Care Centre, Rajkot, Gujarat, India.
Venkatesh R; Narayana Nethralaya, Bangalore, Karnataka, India.
Roy S; Susrut Eye Foundation and Research Centre, Kolkata, West Bengal, India.
Bhavsar M; Novartis Healthcare Pvt. Ltd., Mumbai, Maharashtra, India.
Karcher H; Novartis Pharma AG, Basel, Switzerland.

Clin Ophthalmol ; 17: 2295-2307, 2023.

Article em En | MEDLINE | ID: mdl-37583576

Palavras-chave

India; anti-VEGF; brolucizumab; nAMD; real-world evidence

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Ophthalmol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google